Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives


 21st April 2011 Premier Research

Premier Research Re-brands its Medical Device Business Unit to D-TARGET PHILADELPHIA, April 19 – Premier Research Group Limited announces the re-branding of its Medical Device business unit to D-TARGET, a Premier Research Company. With the continued growth in clinical development activity driven by rising regulatory and commercial demands in the medical device industry, Premier Research recognises this sector has specific needs. D-TARGET was founded in 1997 and acquired by Premier Research in 2007. By reintroducing the name, Premier Research reinforces its focus on this sector and highlights the unique capability, expertise and experience gained by its staff operating as a dedicated Medical Device Contract Research Organization. This division offers a team of medical device specialists with extensive experience in both the European Union and North America. D-TARGET’s team of full time staff is located in more than 30 countries with primary offices in Yverdon, Switzerland and Boston, Massachusetts. Sponsors directly benefit from regional employees with their detailed knowledge of the local clinical research environment and ability to communicate with investigators and regulatory bodies in their own local language. D-TARGET continues to offer a total life cycle partnership for developers of medical device and combination products, ranging from: strategic and tactical advisory services, clinical trial set-up and clinical trial operations through to post marketing surveillance and registry support. In conjunction with the clinical operational staff, D-TARGET has specialist support groups dedicated to: regulatory affairs, ethical committee, competent authority and country specific submissions, protocol writing, statistical analysis and data management, thereby enabling our teams to meet the full range of needs of medical device developers worldwide.


Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |